RankingsPricing
  1. US-listed companies
  2. ABEONA THERAPEUTICS INC.
  3. Financials
  4. Free cash flow

ABEONA THERAPEUTICS INC.ABEO

Market cap
$255.78M
P/E ratio
SummaryFinancials
Period EndFree cash flow (Million USD)YoY (%)
Dec 31, 2024-58+56.56%
Dec 31, 2023-37-14.42%
Dec 31, 2022-44-37.54%
Dec 31, 2021-70+92.14%
Dec 31, 2020-36-47.41%
Dec 31, 2019-69+42.96%
Dec 31, 2018-48+103.21%
Dec 31, 2017-24+75.83%
Dec 31, 2016-14+26.11%
Dec 31, 2015-11+566.11%
Dec 31, 2014-2+161000.00%
Dec 31, 2013-0-99.97%
Dec 31, 2012-4-48.12%
Dec 31, 2011-8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)